Allianz Asset Management GmbH Increases Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Allianz Asset Management GmbH increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 63.6% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,355,643 shares of the medical instruments supplier’s stock after acquiring an additional 526,973 shares during the quarter. Allianz Asset Management GmbH’s holdings in DENTSPLY SIRONA were worth $17,203,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth $26,000. Trust Co. of Toledo NA OH bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at about $27,000. Parkside Financial Bank & Trust boosted its holdings in DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the last quarter. True Wealth Design LLC boosted its holdings in DENTSPLY SIRONA by 273.0% during the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 1,739 shares during the last quarter. Finally, Central Pacific Bank Trust Division grew its position in DENTSPLY SIRONA by 100.0% in the 3rd quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 2,000 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.50% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $13.76 on Friday. The company has a market capitalization of $2.74 billion, a P/E ratio of -3.11, a P/E/G ratio of 1.11 and a beta of 1.01. The business has a fifty day simple moving average of $11.90 and a two-hundred day simple moving average of $12.65. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. DENTSPLY SIRONA Inc. has a 1 year low of $9.85 and a 1 year high of $19.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The business had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. During the same period last year, the company earned $0.50 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% compared to the same quarter last year. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.48%.

Wall Street Analysts Forecast Growth

Several research firms have commented on XRAY. JPMorgan Chase & Co. dropped their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. UBS Group decreased their price target on DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a research report on Tuesday. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Barrington Research reissued an “outperform” rating and issued a $14.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, January 5th. Finally, Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Two equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Reduce” and a consensus target price of $14.25.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.